Philips India has launched its new Azurion system, a breakthrough in image-guided therapy, aimed at equipping Indian interventionalists across cardiology, neurology, vascular, and surgical specialties. Designed to streamline complex procedures and improve patient outcomes, the new system offers advanced C-arm rotation, seamless transition between 2D and 3D imaging, and comprehensive table-side control. This cutting-edge technology enables rapid and precise imaging without compromising the sterile field.
The system also introduces a new head immobiliser, specifically beneficial for stroke patients, enhancing neurovascular care. With features such as automatic beam rotation for correctly oriented images and flexible ergonomic gantry positioning, the Azurion system promises an optimised workflow, faster procedures, and potentially better patient outcomes.
Philips is also enhancing its angio suite uptime with AI-powered remote services via the Philips Service Hub, enabling proactive issue resolution and preventive maintenance.
The system was showcased at Philips Innovation Campus, Bengaluru, where 80 interventionalists witnessed its capabilities. Bharath Sesha, Managing Director of Philips Indian Subcontinent, shared, "Our investment in the new Azurion reflects Philips’ commitment to fostering a world-class healthcare ecosystem in India. This system empowers specialists to address a wide range of critical health conditions efficiently."
Philips Innovation Campus Head, Arvind Vaishnav, added, "We are leveraging advanced AI, software development, and collaborative efforts across global Philips teams to drive innovation tailored to India’s unique healthcare challenges. The Azurion is a testament to our dedication to enhancing patient care."
Dr. Santhosh Joseph of KIMSHEALTH, Trivandrum, praised the system’s Direct-to-Angio-Suite (DTAS) capability, expected to transform stroke care by reducing door-to-puncture time. Dr. T.S. Kler, Chairman at BLK-Max Super Speciality Hospital, noted the Azurion’s benefits in PCI procedures, potentially reducing contrast and radiation doses, thereby improving safety and procedural quality.
_20241220145628_original_image_22.webp)
